Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

GNKG168

Known as: CpG ODN GNKG168, CpG Oligodeoxynucleotide GNKG168 
A synthetic, 21-mer, unmethylated CpG motif-based oligodeoxynucleotide (ODN), with immunostimulatory activity. CpG oligodeoxynucleotide GNKG168 binds… Expand
National Institutes of Health

Related topics

Related topics

2 relations
NCIt Antineoplastic Agent Terminology

Broader (1)

Oligodeoxyribonucleotides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Building a better blast-trap
  • C. Allen
  • Pediatric hematology and oncology
  • 2020
    • Corpus ID: 209748252
In this issue of Pediatric Hematology and Oncology two groups describe studies that analyze safety and efficacy of novel… Expand
Is this relevant?
2019
2019
The TLR9 agonist (GNKG168) induces a unique immune activation pattern in vivo in children with minimal residual disease positive acute leukemia: Results of the TACL T2009-008 phase I study
Abstract Background: Preclinical studies show that TLR9 agonists can eradicate leukemia by induction of immune responses in vivo… Expand
Is this relevant?
2011
2011
Enhanced detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide in combination with pokeweed mitogen and phorbol myristate…
Reproducible cytogenetic analysis in CLL has been limited by the inability to obtain reliable metaphase cells for analysis. CpG… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE